We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

002709:SZSEGuangzhou Tinci Materials Technology Co., Ltd Analysis

Data as of 2026-03-17 - not real-time

CN¥46.76

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Guangzhou Tinci Materials Technology (002709.SZ) is riding a strong bullish technical backdrop, with the 20‑day SMA (≈43.46) comfortably below the current price of 46.76 and the MACD histogram turning positive, indicating momentum to the upside. Support sits around 39.51 and the next resistance near 50.67, giving the stock a clear upside corridor. Volume is increasing, reinforcing the bullish trend, while the 14‑day RSI at 61 suggests the stock is not yet overbought. However, fundamentals tell a cautionary tale: a trailing PE of 65.9 and a price‑to‑book of 5.07 point to a valuation well above the DCF‑derived fair value of roughly 11.9, implying the market is pricing in aggressive growth expectations. The company’s revenue growth of 58.9% and forward EPS outlook of 2.71 support a growth narrative, yet the modest ROE (8.6%) and high price‑to‑sales multiple (5.71) temper enthusiasm. Dividend sustainability appears solid with a low payout ratio of 14% and a modest yield of 0.31%, backed by healthy operating cash flow. In summary, the stock combines robust technical momentum and strong top‑line growth with a markedly stretched valuation, suggesting a nuanced stance for investors.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 7/10

Key Factors

  • Bullish MACD and rising volume
  • Proximity to support level
  • Elevated valuation relative to DCF

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong revenue growth and forward EPS upside
  • Sustained dividend payout capability
  • Industry tailwinds in specialty chemicals and battery materials

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Potential valuation correction
  • Moderate ROE and high price multiples
  • Continued exposure to Chinese regulatory and market dynamics

Key Metrics & Analysis

Financial Health

Revenue Growth58.90%
Profit Margin8.18%
P/E Ratio65.9
ROE8.57%
ROA4.26%
Debt/Equity16.19
P/B Ratio5.1
Op. Cash FlowCN¥1.2B
Free Cash FlowCN¥653.0M

Technical Analysis

TrendBullish
RSI61.1
SupportCN¥39.51
ResistanceCN¥50.67
MA 20CN¥43.46
MA 50CN¥43.42
MA 200CN¥31.77
MACDBullish
VolumeIncreasing
Fear & Greed Index79.45

Valuation

Fair ValueCN¥11.88
Target PriceCN¥52.60
Upside/Downside12.49%
GradeOvervalued
TypeGrowth
Dividend Yield0.31%

Risk Assessment

Beta0.13
Volatility45.22%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.